Evolent Health, Inc.
EVH
$9.19
-$0.80-8.01%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -130.45M | -108.96M | -61.62M | -72.23M | -74.42M |
| Total Depreciation and Amortization | 126.59M | 132.22M | 137.66M | 92.78M | 95.18M |
| Total Amortization of Deferred Charges | 33.69M | 34.25M | 33.95M | 35.99M | 37.45M |
| Total Other Non-Cash Items | 127.98M | 118.63M | 81.79M | 89.49M | 98.21M |
| Change in Net Operating Assets | -134.68M | -101.26M | -116.56M | -11.65M | 19.81M |
| Cash from Operations | -33.33M | 18.42M | 18.77M | 134.38M | 176.23M |
| Capital Expenditure | -88.13M | -39.48M | -33.12M | -41.74M | -31.25M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 577.00K |
| Cash Acquisitions | -19.50M | -19.50M | -19.50M | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.65M | -7.31M | -10.31M | -7.31M | -4.80M |
| Cash from Investing | -113.28M | -66.29M | -62.93M | -49.05M | -35.47M |
| Total Debt Issued | 279.58M | 279.58M | 58.58M | 391.43M | 391.43M |
| Total Debt Repaid | -61.97M | -61.97M | 0.00 | -417.23M | -427.23M |
| Issuance of Common Stock | 2.34M | 2.40M | 3.46M | 6.80M | 8.98M |
| Repurchase of Common Stock | -5.62M | -5.96M | -15.70M | -16.33M | -17.25M |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -19.14M | -19.58M | -20.09M | -20.44M | -20.40M |
| Other Financing Activities | -8.33M | -102.06M | -26.82M | -126.08M | -145.76M |
| Cash from Financing | 186.86M | 92.41M | -565.00K | -181.86M | -210.22M |
| Foreign Exchange rate Adjustments | -227.00K | -168.00K | -229.00K | -111.00K | -190.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 40.02M | 44.37M | -44.96M | -96.65M | -69.65M |